🔬 Science
2h ago
Blocking two proteins reverses lung scarring in pre-clinical study
Source ↗
👁 0
💬 0
A Virginia Tech team has identified a promising new therapeutic strategy for idiopathic pulmonary fibrosis (IPF), showing that blocking two proteins can halt and even reverse lung scarring in pre-clinical models.
Comments (0)